Research, recommendations, and tools

The FoCUS consortium has been working for over three years, thoroughly identifying challenges and designing solutions, involving the perspectives of diverse system stakeholders.

White papers

Tracking the CAR-T revolution:
Analysis of clinical trials of CAR-T and TCR therapies for the treatment of cancer

Payer Perspectives on Financing and Reimbursement of One-time High-cost Durable Treatments

Precision Financing Solutions for Durable / Potentially Curative Therapies

Designing financial solutions to ensure affordable access to cures

Research briefs

Updated projection of US durable cell and gene therapies product-indication approvals

Federal Communication Guidelines

Financing Challenges for Solid-Tumor T-Cell Therapies

SYLK Medicaid Review

Expedited Insurance

Payer Perspectives Survey

Pediatric Gene Therapy Launches

Patient-Caregiver Financial Themes

Medicaid Best Price

Clinical trials and investment trends for novel CAR-T and TCR therapies

Model Contracts for Innovative Oncology Therapies

Role of COE networks in curative cellular oncology therapies

Stop-Loss Insurance or Reinsurance for Multiyear Contracts

Impact of Patient Mobility on Annuity/Performance-Based Contracting

Orphan Reinsurer Benefit Managers (ORBMs)

Impact of Actuarial Risk on Health Plans

Designing Precision Financing for Cures

Payer Segmentation for Precision Financing

Financing Mechanisms Payer Survey